This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- New developments in the imaging of lung cancer
- Enhanced Release of Glucose Into the Intraluminal Space of the Intestine Associated With Metformin Treatment as Revealed by [18F]Fluorodeoxyglucose PET-MRI
- 18F-Fluorodeoxyglucose Positron Emission Tomography in the Management of Patients with Thymic Epithelial Tumors
- Restaging: Should We PERCIST Without Pattern Recognition?
- PET for the Evaluation of Solitary Pulmonary Nodules
- 18F-FDG PET for Mediastinal Staging of Lung Cancer: Which SUV Threshold Makes Sense?
- Accuracy of PET for Diagnosis of Solid Pulmonary Lesions with 18F-FDG Uptake Below the Standardized Uptake Value of 2.5
- PET Evaluation of Lung Cancer
- Response Assessment of Aggressive Non-Hodgkin's Lymphoma by Integrated International Workshop Criteria and Fluorine-18-Fluorodeoxyglucose Positron Emission Tomography
- 18F-FDG Uptake by Primary Tumor as a Predictor of Intratumoral Lymphatic Vessel Invasion and Lymph Node Involvement in Non-Small Cell Lung Cancer: Analysis of a Multicenter Study
- Comparison of Methods to Quantitate 18F-FDG Uptake with PET During Experimental Acute Lung Injury
- 18F-FDG Accumulation with PET for Differentiation Between Benign and Malignant Lesions in the Thorax
- Clinical Applications of 18F-FDG in Oncology
- Performance of sodium iodide based 18F-fluorodeoxyglucose positron emission tomography in the characterization of indeterminate pulmonary nodules or masses
- The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology
- Lesion-to-Background Ratio in Nonattenuation-Corrected Whole-Body FDG PET Images